BEVACIZIMAB

Clinical trials for BEVACIZIMAB explained in plain language.

Never miss a new study

Get alerted when new BEVACIZIMAB trials appear

Sign up with your email to follow new studies for BEVACIZIMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New drug combo shows promise in shrinking liver tumors before surgery

Disease control Recruiting now

This study tests whether giving two drugs (sintilimab and bevacizumab) before surgery can lower the chance of liver cancer coming back. It involves 37 adults with resectable liver cancer that is beyond standard transplant criteria. The goal is to see if this approach improves 1-y…

Matched conditions: BEVACIZIMAB

Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated May 12, 2026 13:41 UTC

BEVACIZIMAB

Get alerted when new BEVACIZIMAB trials appear

New drug combo shows promise in shrinking liver tumors before surgery